Biocon Limited has informed the Exchange about Qualified Institutions Placement - Issue Opening

Fund Raising View source PDF Explain this filing

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.5%Reaction day

₹370.90

prior close

₹377.00

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-0.1%+1.7% vs market

Pharmaceuticals peers, median of 154sector-0.3%+1.8% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Midcap 150 and 1.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.7

10m

-0.8

15m

-1.1

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.5-0.1+1.7-0.3+1.8

Next day

+2.2+0.1+2.1-0.3+2.4

+1.5+0.1+1.4-0.6+2.2

+1.1-0.3+1.4-1.7+2.8

-1.6-2.8+1.2-3.7+2.1

-1.6-3.8+2.2-4.8+3.2

-1.0-4.3+3.3-4.8+3.8

15d

-0.9-0.1-0.8-2.6+1.7

+1.9-0.3+2.2-2.6+4.5

+3.4-7.8+11.2-9.9+13.3

-6.6-3.5-3.1-4.6-2.0

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Biocon Limited has opened its Qualified Institutions Placement (QIP) issue today, January 12, 2026, to raise funds by issuing equity shares of face value ₹5 each to institutional investors. The floor price for the issue has been fixed at ₹387.74 per share, as per the SEBI ICDR pricing formula. The company may offer a discount of up to 5% on this floor price, with the final issue price to be determined in consultation with the book running lead managers. The QIP was approved by the Board on December 6, 2025, and by shareholders at the EGM held on December 31, 2025. The trading window for dealing in Biocon shares remains closed until further notice.

Likely market impact

This QIP will lead to dilution of existing shareholders but will bring fresh equity capital to support the company's growth plans. Short-term stock price may face pressure depending on the final issue price relative to the current market price and how the raised funds are deployed.